Strikingly, SIRT3 knock-out mice have been reported to present an exaggerated profibrotic response to bleomycin [24,41,42], whereas transgenic mice with whole body SIRT3 overexpression were found to be protected from bleomycin-induced lung fibrosis [41]. The gene discussed is SIRT3; the disease is pulmonary fibrosis.